205 related articles for article (PubMed ID: 26090593)
21. Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines.
Rochford R; Cannon MJ; Sabbe RE; Adusumilli K; Picchio G; Glynn JM; Noonan DJ; Mosier DE; Hobbs MV
Viral Immunol; 1997; 10(4):183-95. PubMed ID: 9473149
[TBL] [Abstract][Full Text] [Related]
22. Propagation of EBV-driven Lymphomatous Transformation of Peripheral Blood B Cells by Immunomodulators and Biologics Used in the Treatment of Inflammatory Bowel Disease.
Levhar N; Ungar B; Kopylov U; Fudim E; Yavzori M; Picard O; Amariglio N; Chowers Y; Shemer-Avni Y; Mao R; Chen MH; Ye Z; Eliakim R; Ben-Horin S
Inflamm Bowel Dis; 2020 Aug; 26(9):1330-1339. PubMed ID: 32322878
[TBL] [Abstract][Full Text] [Related]
23. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
[TBL] [Abstract][Full Text] [Related]
24. [Application of Epstein-Barr virus-transformed B lymphoblastic cells in identification of CTL epitopes specific for Hantaan virus].
Wang ML; Zhang QH; Wang JP; Li YM; Ma Y; Jin BQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jan; 25(1):20-2. PubMed ID: 19126382
[TBL] [Abstract][Full Text] [Related]
25. Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation.
Yajima M; Kanda T; Takada K
J Virol; 2005 Apr; 79(7):4298-307. PubMed ID: 15767430
[TBL] [Abstract][Full Text] [Related]
26. Rheumatoid factors induce signaling from B cells, leading to Epstein-Barr virus and B-cell activation.
Yang L; Hakoda M; Iwabuchi K; Takeda T; Koike T; Kamatani N; Takada K
J Virol; 2004 Sep; 78(18):9918-23. PubMed ID: 15331725
[TBL] [Abstract][Full Text] [Related]
27. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus (EBV) and human hematopoietic cell lines: a review.
Tatsumi E
Hum Cell; 1992 Mar; 5(1):79-86. PubMed ID: 1329932
[TBL] [Abstract][Full Text] [Related]
29. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R
Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines.
Wendel-Hansen V; Sällström J; De Campos-Lima PO; Kjellström G; Sandlund A; Siegbahn A; Carlsson M; Nilsson K; Rosén A
Leukemia; 1994 Mar; 8(3):476-84. PubMed ID: 8127151
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation.
Wu Y; Maruo S; Yajima M; Kanda T; Takada K
J Virol; 2007 Oct; 81(20):11236-45. PubMed ID: 17686859
[TBL] [Abstract][Full Text] [Related]
32. CD80 (B7.1) and CD86 (B7.2) induce EBV-transformed B cell apoptosis through the Fas/FasL pathway.
Park GB; Kim YS; Lee HK; Cho DH; Kim D; Hur DY
Int J Oncol; 2013 Nov; 43(5):1531-40. PubMed ID: 24008628
[TBL] [Abstract][Full Text] [Related]
33. Skewed T cell receptor repertoire of Vdelta1(+) gammadelta T lymphocytes after human allogeneic haematopoietic stem cell transplantation and the potential role for Epstein-Barr virus-infected B cells in clonal restriction.
Fujishima N; Hirokawa M; Fujishima M; Yamashita J; Saitoh H; Ichikawa Y; Horiuchi T; Kawabata Y; Sawada KI
Clin Exp Immunol; 2007 Jul; 149(1):70-9. PubMed ID: 17425654
[TBL] [Abstract][Full Text] [Related]
34. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
[TBL] [Abstract][Full Text] [Related]
35. Reconsideration of senescence, immortalization and telomere maintenance of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines.
Sugimoto M; Ide T; Goto M; Furuichi Y
Mech Ageing Dev; 1999 Feb; 107(1):51-60. PubMed ID: 10197788
[TBL] [Abstract][Full Text] [Related]
36. [Preparation of human anti-HBs from volunteers with hepatitis B vaccine boost vaccination by modified B-cell immortalization technique].
Lou HB; Zhou YP; Zhou FY; Zhang MX; Wei JF; Zeng YL; Wang JJ; Wang YJ; Wu AH; Hou JL
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):949-52. PubMed ID: 20501364
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporine promotes epstein-barr virus-infected human B-cell transformation assayed by three correlated assay methods.
Chen C; Johnston TD; Jeon H; Gedaly R; McHugh P; Ranjan D
Transplant Proc; 2009; 41(1):366-70. PubMed ID: 19249558
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of cell growth and Epstein-Barr virus reactivation by CD40 stimulation in Epstein-Barr virus-transformed B cells.
Fukuda M; Satoh TA; Takanashi M; Hirai K; Ohnishi E; Sairenji T
Viral Immunol; 2000; 13(2):215-29. PubMed ID: 10893001
[TBL] [Abstract][Full Text] [Related]
39. [Recombinant AAV-LMP-induced LMP specific cytotoxic response to autologous lymphoblastoid cell lines tranformed by Epstein-Barr virus].
Zhao F; Liu H; Zhou L; Cai W; Du B; Ye S; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):247-51. PubMed ID: 15617340
[TBL] [Abstract][Full Text] [Related]
40. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
Kalla M; Hammerschmidt W
Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
